C12N 2770/26011
Flexiviridae
C12N2770/26011 (Flexiviridae) appears on 24 US grants and 28 published applications in this corpus.
Search patents in C12N- Granted patents
- 24
- Published applications
- 28
- Assignees
- 15
- Inventors
- 57
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 1 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 3 |
| 2010 | 1 | 3 |
| 2011 | 0 | 2 |
| 2012 | 2 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 3 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 2 |
| 2020 | 1 | 2 |
| 2021 | 1 | 2 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 2 | 2 |
| 2025 | 1 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2770/26022New viral proteins or individual genes, new structural or functional aspects ofIndexing code12
- C12N 2770/26023Virus like particles [vlp]Indexing code10
- C12N 2770/26041Use of virus, viral particle or viral elements as a vectorIndexing code8
- C12N 2770/26021Viruses as suchIndexing code3
- C12N 2770/26071Demonstrated in vivo effectIndexing code3
- C12N 2770/26033Use of viral protein as therapeutic agent other than vaccineIndexing code2
- C12N 2770/26031Uses of virus other than therapeutic or vaccineIndexing code1
- C12N 2770/26034Use of virus or viral component as vaccineIndexing code1
All 12 subgroupsShow fewer
Recent patents
- Plant vectors, compositions and uses relating thereto24 Feb 2026US 12,559,768 B2The Regents of the University of California
- Methods and compositions for controlling plant viral infection9 Sep 2025US 12,408,674 B2Monsanto Technology LLC
- Cancer immunotherapy using virus particles27 Aug 2024US 12,070,478 B2Case Western Reserve University
- Anti-cancer plant virus particles linked to HER2 antigens4 Jun 2024US 11,998,594 B2Case Western Reserve University
- Cancer immunotherapy using virus particles28 Feb 2023US 11,590,183 B2Case Western Reserve University
- One-step supramolecular multifunctional coating on plant virus nanoparticles for bioimaging and therapeutic applications12 Jun 2025US 2025/0186607 A1The Regents of the University of California
- Cancer immunotherapy using virus particles13 Feb 2025US 2025/0049866 A1
- Plant Vectors, Compositions and Uses Relating Thereto22 Aug 2024US 2024/0279675 A1The Regents of the University of California
- Cancer immunotherapy using virus particles22 Feb 2024US 2024/0058401 A1Case Western Reserve University
- Plant Vectors, Compositions and Uses Relating Thereto18 Nov 2021US 2021/0355499 A1University of Maryland, College Park
Most cited
By later US patents
- Method of producing a chimeric protein14US 6,232,099 B1Scottish Crop Research Institute · 2001
- Coat protein gene for the FLA83 W strain of papaya ringspot virus9US 6,002,072 ACornell Research Foundation, Inc. · 1999
- Satellite RNA from bamboo mosaic virus as a vector for foreign gene expression in plants6US 5,849,891 ANational Science Council · 1998
- Adjuvant viral particle3US 7,641,896 B2Folia Biotech Inc. · 2010
- Rupestris stem pitting associated virus nucleic acids, proteins, and their uses2US 6,093,544 ACornell Research Foundation, Inc. · 2000